DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Rating of “Hold” from Brokerages

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has been given a consensus rating of “Hold” by the fifteen ratings firms that are currently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $13.4167.

A number of research firms have recently issued reports on XRAY. Mizuho dropped their price target on DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 6th. Barclays reduced their price objective on DENTSPLY SIRONA from $12.00 to $9.00 and set an “underweight” rating for the company in a research report on Thursday, June 4th. Weiss Ratings cut DENTSPLY SIRONA from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 6th. Citigroup initiated coverage on DENTSPLY SIRONA in a research note on Wednesday, April 15th. They set a “sell” rating and a $10.00 price target for the company. Finally, BMO Capital Markets started coverage on shares of DENTSPLY SIRONA in a research note on Wednesday, July 8th. They issued a “market perform” rating and a $12.00 price objective on the stock.

Insider Activity at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Michael J. Barber bought 15,175 shares of DENTSPLY SIRONA stock in a transaction on Thursday, June 11th. The stock was acquired at an average cost of $9.88 per share, with a total value of $149,929.00. Following the completion of the acquisition, the director owned 55,943 shares in the company, valued at approximately $552,716.84. This represents a 37.22% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Brian P. Mckeon purchased 10,000 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was acquired at an average price of $10.12 per share, for a total transaction of $101,200.00. Following the completion of the transaction, the director directly owned 10,000 shares of the company’s stock, valued at approximately $101,200. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders acquired 35,160 shares of company stock worth $351,179. 0.46% of the stock is owned by company insiders.

Hedge Funds Weigh In On DENTSPLY SIRONA

Institutional investors have recently bought and sold shares of the stock. First Eagle Investment Management LLC lifted its holdings in DENTSPLY SIRONA by 3.2% during the fourth quarter. First Eagle Investment Management LLC now owns 14,640,555 shares of the medical instruments supplier’s stock valued at $167,342,000 after purchasing an additional 458,744 shares in the last quarter. Sound Income Strategies LLC increased its stake in shares of DENTSPLY SIRONA by 32.3% in the fourth quarter. Sound Income Strategies LLC now owns 611,308 shares of the medical instruments supplier’s stock worth $7,464,000 after purchasing an additional 149,384 shares in the last quarter. Invenomic Capital Management LP increased its stake in shares of DENTSPLY SIRONA by 48.7% in the third quarter. Invenomic Capital Management LP now owns 4,351,199 shares of the medical instruments supplier’s stock worth $55,217,000 after purchasing an additional 1,425,637 shares in the last quarter. Crawford Investment Counsel Inc. bought a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at $1,104,000. Finally, Great Hill Capital LLC bought a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at $8,267,000. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Stock Up 1.5%

Shares of DENTSPLY SIRONA stock opened at $14.06 on Tuesday. The company has a market cap of $2.82 billion, a price-to-earnings ratio of -4.46, a price-to-earnings-growth ratio of 1.67 and a beta of 0.89. The company’s 50 day moving average is $10.81 and its 200 day moving average is $11.74. DENTSPLY SIRONA has a twelve month low of $9.40 and a twelve month high of $17.09. The company has a quick ratio of 0.98, a current ratio of 1.53 and a debt-to-equity ratio of 1.52.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Tuesday, May 5th. The medical instruments supplier reported $0.27 EPS for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.01). The company had revenue of $880.00 million during the quarter, compared to the consensus estimate of $841.80 million. DENTSPLY SIRONA had a positive return on equity of 18.83% and a negative net margin of 17.06%.The company’s revenue for the quarter was up .1% on a year-over-year basis. During the same period last year, the firm posted $0.43 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Research analysts anticipate that DENTSPLY SIRONA will post 1.42 EPS for the current year.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.